Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders

• Published in: Diabetic medicine 2021-02, Vol.38 (2), p.e14415-n/a
• Main Authors: Eslami, M., Bahar, A., Hemati, M., Rasouli Nejad, Z., Mehranfar, F., Karami, S., Kobyliak, N. M., Yousefi, B.
• Format: Article
• Language: English
• Subjects: Amino acids; Amino Acids, Branched-Chain - metabolism; Bile Acids and Salts - metabolism; Children; Colon - microbiology; Cytokines; Cytokines - immunology; Cytokines - metabolism; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - immunology; Diabetes Mellitus, Type 2 - metabolism; Diet; Dysbacteriosis; Dysbiosis - immunology; Dysbiosis - metabolism; Fatty acids; Fatty Acids, Volatile - metabolism; Gastrointestinal Microbiome - immunology; Gastrointestinal Microbiome - physiology; Glucose metabolism; Homeostasis; Humans; Inflammation; Inflammation - immunology; Inflammation - metabolism; Intestine; Lipopolysaccharides; Lipopolysaccharides - metabolism; Medical innovations; Metabolic disorders; Microbiomes; Microbiota; Transcription
• ISSN: 0742-3071; 1464-5491
• DOI: 10.1111/dme.14415

In this review, the numerous possible mechanisms that provide supportive evidence for how colonic dysbiosis denotes metabolic dysfunction, dysregulates glucose homeostasis and leads to diabetes mellitus and related metabolic disorders are defined. Information was gathered from articles identified by systematic reviews and searches using Google, PubMed and Scopus. The composition of the colonic microbiota plays an integral role in maintaining host homeostasis by affecting both metabolic activities and underlying functional gene transcription in individuals with diabetes and related metabolic disorders. Increased colonic microbiome‐derived concentrations of lipopolysaccharides, also known as ‘metabolic endotoxaemia’, as well as alterations in bile acid metabolism, short‐chain fatty acids, intestinal hormones and branched‐chain amino acid secretion have been associated with the diverse production of pro‐inflammatory cytokines and the recruitment of inflammatory cells. It has been shown that changes to intestinal bacterial composition are significant even in early childhood and are associated with the pathogenesis of both types of diabetes. We hope that an improved understanding of related mechanisms linking the colonic microbiome with glucose metabolism might provide for innovative therapeutic approaches that would bring the ideal intestinal ecosystem to a state of optimal health, thus preventing and treating diabetes and related metabolic disorders.